LY 2157299 - Galunisertib

Based on 589 reference(s) in Google Scholar 9 10 589

Axon 1491

CAS [700874-72-2]

MF C22H19N5O
MW 369.42

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

LY 2157299

Description

Orally active transforming growth factor β receptor (TGF-βR) kinase inhibitor under clinical development; IC50 values to be 86 nm (TβR1) and 2 nM (TβR2) respectively.

KEYWORDS: LY 2157299 | supplier | TGF-βR2 inhibitor | Galunisertib | LY2157299 | LY-2157299 | CAS [700874-72-2] | TGF-beta | transforming growth factor | TβR1 | TβR2 | antagonist | non-small cell lung cancer | NSCLC | Smad | pSmad

Order
Size Unit Price Stock
2 mg €70.00 In Stock
5 mg €95.00 In Stock
25 mg €335.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €140.00 In Stock
2 x 25 mg €480.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...